Wellington Management
http://www.wellington.comWellington Management is an independent investment management company. The firm invests in a broad range of asset classes including global equity, fixed income, currency and commodity markets, including multi-strategy, specialty and alternative investment approaches.
View Older Stories View More Recent Stories
-
Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics
-
Increased Funding for Pancreatic Cancer Trials & Treatments Rising along with Demand for New Drugs
-
EXL (EXLS) Appoints Sarah Williamson to its Board
-
Sarah Williamson appointed to the EXL Board of Directors
-
Wellington Management Closes Fourth Late-Stage Private Fund, Exceeding $2.5 Billion Target
-
Exclusive-Cloud banking vendor nCino explores sale -sources
-
Hartford Funds Announces the Closure and Liquidation of the Hartford Schroders ESG US Equity ETF
-
Form SC 13G/A Syneos Health, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A VERACYTE, INC. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G Nuvei Corp Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A NanoString Technologies Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
BetterUp Now Available on SAP® Store
-
Upstream Bio Announces $200M Series B Financing to Advance UPB-101 for Allergic and Inflammatory Diseases
-
Alkeus Announces $150 Million Series B Financing, Supporting Rapid Registration Path for gildeuretinol (ALK-001) in the Treatment of Stargardt Disease
-
Investors who showed Q1 bets on Nvidia may have got boost as it joined $1 trillion club
-
Vanguard Announces Advisory Changes for Two Equity Funds
-
MBX Biosciences to Participate in Jefferies Healthcare Conference
-
Form D/A Wellington Management
-
BetterUp and Carahsoft Partner to Address U.S. Government Agencies’ Mindsets for Mission Readiness
-
BetterUp and Carahsoft Partner to Address U.S. Government Agencies’ Mindsets for Mission Readiness
-
Boundless Bio Announces $100 Million Oversubscribed Series C Financing co-led by Leaps by Bayer and RA Capital Management to Advance the First ecDNA-Directed Therapies (ecDTx) for Patients with Oncoge
-
Form 13F-HR WELLINGTON MANAGEMENT For: Mar 31
-
Form SC 13G/A Celldex Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A IRONWOOD PHARMACEUTICALS Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
MBX Biosciences to Participate in May Investor Conferences
-
Scribe Therapeutics Announces Oral Presentation at 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
-
Diebold Nixdorf Shareholders Elect Directors at Annual Meeting
-
SPAN Raises $96 Million to Accelerate Product Innovation for Its Award-Winning Home Electrification Technology
-
Clerkie raises $33M Series A funding from top investors to address the broken debt system
-
Income Research + Management Hires Chief Strategy Officer
-
Wellington Management Announces Close of Biomedical Innovation II
-
Saluda Medical Announces $150M Equity Financing Led by Wellington Management with Fidelity Management & Research Company and TPG
-
Financial Institutions Join Avalanche Evergreen Subnet, ‘Spruce’, to Drive On-Chain Finance Innovation
-
Global Asset Management Forum Annual Conference 2023 Kicks off
-
Form SC 13G/A AGIOS PHARMACEUTICALS, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Aclaris Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Repay Holdings Corp Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A FLUOR CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A BAXTER INTERNATIONAL Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
MBX Biosciences to Participate in the Needham 22nd Annual Healthcare Conference
-
BetterUp Announces Sales Performance Solution on Salesforce AppExchange
-
HeartFlow, Leader in Revolutionizing Precision Heart Care, Closes $215 Million in Series F Funding Led by Bain Capital Life Sciences
-
HeartFlow, Leader in Revolutionizing Precision Heart Care, Closes $215 Million in Series F Funding Led by Bain Capital Life Sciences
-
JOHN HANCOCK HEDGED EQUITY & INCOME FUND REQUIRED NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)
-
Scribe Therapeutics to Participate in Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days
-
Top Investment Management Firms Commit $13 Million to Girls Who Invest
-
Top Investment Management Firms Commit $13 Million to Girls Who Invest
-
Zephyr Releases PSN Top Guns List for Q4 2022 Highlighting Best-In-Class Separate Accounts, Managed Accounts and Managed ETF Strategies
-
FalconX Wins FinTech Breakthrough Award for Decentralized Finance Innovation
-
Holding(s) in Company

